Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
Georges GE, Maris M, Sandmaier BM, Malone DG, Feinstein L, Niederweiser D, Shizuru JA, McSweeney PA, Chauncey TR, Agura E, Little MT, Sahebi F, Hegenbart U, Pulsipher MA, Bruno B, Forman S, Woolfrey AE, Radich JP, Blume KG, Storb R. Georges GE, et al. Among authors: chauncey tr. Int J Hematol. 2002 Aug;76 Suppl 1:184-9. doi: 10.1007/BF03165242. Int J Hematol. 2002. PMID: 12430851 Clinical Trial.
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.
Anderson JE, Appelbaum FR, Schoch G, Gooley T, Anasetti C, Bensinger WI, Bryant E, Buckner CD, Chauncey TR, Clift RA, Doney K, Flowers M, Hansen JA, Martin PJ, Matthews DC, Sanders JE, Shulman H, Sullivan KM, Witherspoon RP, Storb R. Anderson JE, et al. Among authors: chauncey tr. Blood. 1996 Jan 1;87(1):51-8. Blood. 1996. PMID: 8547676 Free article. Clinical Trial.
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Anderson JE, Appelbaum FR, Schoch G, Gooley T, Anasetti C, Bensinger WI, Bryant E, Buckner CD, Chauncey T, Clift RA, et al. Anderson JE, et al. J Clin Oncol. 1996 Jan;14(1):220-6. doi: 10.1200/JCO.1996.14.1.220. J Clin Oncol. 1996. PMID: 8558201 Clinical Trial.
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.
Bensinger WI, Rowley SD, Demirer T, Lilleby K, Schiffman K, Clift RA, Appelbaum FR, Fefer A, Barnett T, Storb R, Chauncey T, Maziarz RT, Klarnet J, McSweeney P, Holmberg L, Maloney DG, Weaver CH, Buckner CD. Bensinger WI, et al. J Clin Oncol. 1996 May;14(5):1447-56. doi: 10.1200/JCO.1996.14.5.1447. J Clin Oncol. 1996. PMID: 8622058 Clinical Trial.
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
Brunvand MW, Bensinger WI, Soll E, Weaver CH, Rowley SD, Appelbaum FR, Lilleby K, Clift RA, Gooley TA, Press OW, Fefer A, Storb R, Sanders JE, Martin PL, Chauncey T, Maziarz RT, Zuckerman N, Montgomery P, Dorn R, Weiden PL, Demirer T, Holmberg LA, Schiffman K, McSweeney PA, Buckner CD, et al. Brunvand MW, et al. Bone Marrow Transplant. 1996 Jul;18(1):131-41. Bone Marrow Transplant. 1996. PMID: 8832006 Clinical Trial.
151 results